SonALAsense Presents Data From Study in Patients With Pediatric Brain Tumor
13 Dec 2023 //
BUSINESSWIRE
SonALAsense Welcomes Dr. Ely Benaim as CMO & Executive VP of DevP
09 May 2023 //
BUSINESSWIRE
SonALAsense Announces Completion of First Cohort in Phase 2 Study of SONALA-001
08 Mar 2023 //
BUSINESSWIRE